Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.
1. The Central Drugs Standard Control Organisation (CDSCO) has introduced a prior intimation system for the submission of applications for analytical or non-clinical testing in Forms CT-10, CT-12, and CT-13 under the New Drugs and Clinical Trials Rules, 2019 through the National Single Window System (NSWS) portal. The system does not apply to sex hormones, cytotoxic drugs, beta-lactam drugs, biologics containing live microorganisms, or narcotic and psychotropic substances.
Source: short-url.org/1qC6E
2. The Government of India is reportedly considering stricter regulation of nicotine lozenges to curb access by minors and non-smokers. The Drugs Technical Advisory Board (DTAB) has reportedly recommended removing 2 mg nicotine lozenges from the exemption, which currently allows certain nicotine replacement therapy (NRT) products to be sold without a drug sale licence. If implemented, nicotine lozenges would largely be restricted to sale through licensed pharmacies.
Source: short-url.org/1lt4O
3. India’s central food regulatory authority (FSSAI) has recently in a Central Advisory Committee meeting urged states and UTs to strengthen enforcement against high-risk food commodities such as milk, edible oils, spices and honey. It called for risk-based inspections, faster recruitment of food safety officers, improved grievance redressal systems, and data-driven surveillance to strengthen monitoring and improve nationwide food safety oversight.
Source: short-url.org/1lt4V
4. Karnataka government has reportedly proposed banning the use of social media by children under the age of sixteen. Chief Minister Siddaramaiah announced the move during the state budget speech, stating that the measure aims to reduce the harmful effects of excessive mobile phone usage on minors across the state.
Source: short-url.org/1lt4-
5. India has outlined a five-pillar strategy to integrate artificial intelligence across healthcare, focusing on governance, data platforms, innovation, workforce capacity, and real-world validation. The framework aims to scale AI-driven diagnostics, public-health surveillance, and digital health infrastructure for pharma, med-tech, and health-tech companies to collaborate in data-driven healthcare innovation.
Source: short-url.org/1lt50